Top Section/Ad
Top Section/Ad
Most recent
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
Pair enjoyed strong execution and tight pricing as US high grade credit remained resilient in the face of a sell-off in equity markets
More articles/Ad
More articles/Ad
More articles
-
The €813m deal is multiple times covered -
Pharma company wins blowout order book as investors pile in for yield
-
IPO was covered throughout the initial range on day one
-
The medical equipment company is funding its acquisition of Icelandic peer Kerecis with equity
-
The company’s share price dropped after H2 results
-
A new bull market for growth stocks in the US is giving issuers an opportunity to raise capital
